Skin Lesions and Treatment With Tumor Necrosis Factor Alpha ...

Skin Adverse Reactions Related to TNF Alpha Inhibitors - IntechOpen

A wide range of skin immune-mediated adverse reactions have been described in relation with using anti-TNFα agents. Frequently reported reactions are vasculitis ...

Psoriatic skin lesions induced by tumor necrosis factor antagonist ...

Numerous reports of the induction or worsening of psoriasis in patients treated with tumor necrosis factor (TNF) antagonists indicate that this is not a rare ...

Tumor necrosis factor: Links with inflammation and medical conditions

In people with autoimmune diseases, however, high levels of TNF in the blood can cause unnecessary inflammation, resulting in painful symptoms.

Dermal lesions associated with anti–tumor necrosis factor α therapy ...

Results: Higher prevalence of dermal lesions was noted in the patients on anti–TNF-α therapy than in the individuals not receiving such ...

Immune-Mediated Skin Reactions to Tumor Necrosis Inhibitors: A ...

Abstract. Background: Tumor necrosis factor α (TNF) inhibitors are used to treat different inflammatory diseases.

Severe skin lesions cause patients with inflammatory bowel disease ...

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. · Figures · 165 Citations · 41 References ...

Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis ...

Limitation: Retrospective nature and no matched control group of patients not receiving anti-TNF therapy. Conclusion: Skin lesions occur frequently in ...

Tumor Necrosis Factor (TNF) Inhibitors

TNF inhibitors are drugs that help stop inflammation and are used to treat inflammatory conditions such as rheumatoid arthritis (RA), psoriatic arthritis, ...

Autoimmune Bullous Skin Diseases Occurring under Anti-Tumor ...

The occurrence of autoimmune bullous skin disease in patients undergoing tumor necrosis factor (TNF)-targeted therapy has never been described.

What Is TNF (Tumor Necrosis Factor)? - Rheumatoid Arthritis - WebMD

For example, if you have psoriasis, high levels of TNF play a role in the raised, red skin plaques that come with the disease. For people with ...

Death by TNF: a road to inflammation | Nature Reviews Immunology

Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most ...

Psoriatic skin lesions induced by tumor necrosis factor antagonist ...

TNF antagonist–induced psoriasis is a newly recognized adverse effect of these medications that typically does not require therapy cessation.

Tumor necrosis factor-α inhibitor-induced psoriasis

The majority of patients received skin-directed therapy, though patients who discontinued TNF therapy had the greatest resolution of symptoms ( ...

Dermatological conditions during TNF-α-blocking therapy in patients ...

... TNF-α-blocking therapy (0.09 events per patient-year, P < 0.0005). The events recorded most frequently were skin infections (n = 33), eczema ...

Paradoxical Skin Reactions to Biologics in Patients With ... - Frontiers

The efficacy and tolerability of biological agents, from the initial tumour necrosis factor (TNF)-α inhibitors to the new anti-cytokine ...

Anti-TNF-α Induced Perianal Skin Rash Mimicking Cutaneous...

Purpose: Anti-tumor necrosis factor (Anti-TNF)-α therapy is associated with a variety of cutaneous adverse reactions. New onset psoriasis after initiation ...

Immunopathogenesis of hidradenitis suppurativa and ... - JCI Insight

Anti–TNF-α therapy preferentially attenuates the B cell infiltrate in HS skin. Given the magnitude and heterogeneity of the inflammatory response in skin of HS ...

Alopecia secondary to anti-tumor necrosis factor-alpha therapy

Biologic drugs represent a substantial progress in the treatment of chronic inflammatory immunologic diseases. However, its crescent use has revealed seldom ...

IDDF2024-ABS-0047 Is ustekinumab useful for crohn's disease ... - Gut

In this study, we investigated the therapeutic effect of UST on CD patients with paradoxical skin reactions to TNF inhibitors (TNFi) and long-term efficacy.

Evaluating safety and compatibility of anti-tumor necrosis factor ...

Of note, anti-TNFα therapy can induce other cutaneous connective tissue disorders and autoimmune diseases, which may have parallels to CLE. Recent literature ...